Nexeum Pharmaceuticals
Levosulpiride (75mg) + Esomeprazole (40mg)
Esmodac-L Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving symptoms such as heartburn, stomach pain, or irritation.
Capsule SR
Esmodac-L Capsule SR is a prescription medicine used in the treatment of gastroesophageal reflux disease (acid reflux). It works by relieving the symptoms such as heartburn, stomach pain, or irritation. It also neutralizes the acid production in the stomach to prevent discomfort.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Esmodac-L Capsule SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Esmodac-L Capsule SR.
Information regarding the use of Esmodac-L Capsule SR during breastfeeding is not available. Please consult your doctor.
Esmodac-L Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Esmodac-L Capsule SR is a combination of two medicines: Levosulpiride and Esomeprazole.
It is a well-tolerated medicine and provides relief for a long time. Take it one hour before the meal preferably in the morning. Inform your doctor if you get watery diarrhea fever or stomach pain that does not go away.
Store Esmodac-L Capsule SR in its original container, tightly closed. Follow the storage instructions on the product packaging or label. Do not consume any unused medication, and ensure it is inaccessible to pets, children, and other individuals.
Take Esmodac-L Capsule SR exactly as directed by your doctor. It is generally recommended to take one capsule daily on an empty stomach.
Use of Esmodac-L Capsule SR should be avoided in patients with known allergies to any components or excipients of this medicine.
Yes, some individuals may experience dizziness (feeling faint, weak, unsteady, or lightheaded) while taking Esmodac-L Capsule SR. If experiencing dizziness, it is advisable to rest and resume medication when feeling better.
Studies on adults have suggested that treatment with Esmodac-L Capsule SR may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine. The risk appears higher for patients receiving high doses, which could mean multiple daily doses and long-term therapy (one year or longer).